Please wait while the formulary information is being retrieved.
KLARON (SULFACETAMIDE SODIUM)
- Acne vulgaris
- Sulfacetamide Sodium (acne) Topical Suspension
- Sulfacetamide Sodium (acne) Lotion (suspension)
- Klaron Topical Susp
- Klaron Lotion (suspension)
- By Indication
(acne) 10 % lotion (suspension)
- Dosage information is not available
(acne) 10 % lotion (suspension)
- Dosage information is not available
10 % lotion (suspension)
- Dosage information is not available
10 % lotion (suspension)
- Dosage information is not available
Acne vulgaris
- Apply to the affected area(s) by topical route 2 times per day
- None
Contraindicated
- Silvadene
- silver sulfadiazine
- Ssd
- Thermazene
Severe
Moderate
- None
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemolytic anemia from PK and g6PD deficiencies
Contraindicated
- None
Severe
Moderate
- None
KLARON (SULFACETAMIDE SODIUM)
- Acne vulgaris
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Agranulocytosis
- Blood dyscrasias
- Erythema
- Glucose-6-phosphate dehydrogenase deficiency anemia
- Hepatic necrosis
- Hypersensitivity drug reaction
- Neutropenic disorder
- Pruritus of skin
- Skin irritation
- Skin rash
- Stevens-johnson syndrome
- Systemic lupus erythematosus
- Toxic epidermal necrolysis
Less Severe
- None
Contraindicated
Sulfacetamide Sodium (Top)
Not recommended in infants under 2 months. May cause kernicterus.
- 1 Day – 59 Days
- 1 Not recommended in infants under 2 months. May cause kernicterus.
Severe Precaution
None
Management or Monitoring Precaution
None
Sulfacetamide Sodium (ophth & Top)
- Severity Level:
C
- Additional Notes: Insufficient human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Sulfacetamide (ophth, Top, Vag)
Absorp unknown;Kernicterus risk in newborn;Sulfas not rec if g6Pd def infant
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Absorp unknown;Kernicterus risk in newborn;Sulfas not rec if g6Pd def infant |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acne vulgaris | |
| L70.0 | Acne vulgaris |
| 0-9 | A-Z |
|---|---|
| L70.0 | Acne vulgaris |
Formulary Reference Tool